Results per Page:
La hipertranscripción predice los resultados del cáncer gracias al Pol II
Del Laboratorio Henikoff, División de Ciencias Básicas
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
New insights into advanced bladder cancer
First-of-its-kind rapid autopsy program helps reveal deadly disease’s potential vulnerabilities
Reducing the cancer burden for women around the globe
Dr. Nancy Davidson on improving outcomes for women with breast, lung and colorectal cancer
Researchers ‘shocked’ to see how often experts misdiagnose certain brain tumors in kids
New study: Molecular tests reveal critical differences in cancers thought to be the same, highlight implications for treatment
Bringing personalized oncology to cancer prediction — and prevention
Unique $2.4M NCI-NIEHS award teams Hutch cancer geneticists, epidemiologists and oncologists to use mutation rate to predict individual cancer risk
Personalized medicine for head and neck cancer
from the Mendez lab, Clinical Research Division, and Kemp lab, Human Biology Division
Q & A with Dr. Peggy Porter: Targeted breast cancer treatments require diverse research data
Breast cancer researcher discusses need to extend research and results to minority women
Dr. Cecilia Yeung awarded Hyundai Scholar Hope Grant for childhood leukemia research
Yeung developing test to diagnose acute leukemia earlier, provide personalized treatment
Proteowhatnow? 6 questions with a proteomics expert
How a new technology could help identify the best cancer treatment for an individual patient
What’s new in prostate cancer? 5 things to watch
Highlights from the Institute for Prostate Cancer Research 2017 community symposium
Improving survival and reducing side effects in Hodgkin lymphoma
New data from cooperative trial suggest PET imaging could guide treatment
Challenging the notion of personalized medicine
Study suggests effective brain cancer therapies should focus on early similarities between tumors rather than differences